Sotac Pharmaceuticals Limited — Board Meeting, 28-05-2025: Outcome of Board Meeting

Sotac Pharmaceuticals has announced a board meeting to approve its consolidated financial results for the year ended March 31, 2025. Revenue rose to Rs 96.99 Cr, with profit after tax jumping to Rs 9.28 Cr from Rs 3.58 Cr last year. The board declared a final dividend of Rs 0.10 per share, subject to shareholder approval. EBITDA saw strong growth, supported by stable raw material and finance costs. The balance sheet shows equity at Rs 53.25 Cr and long-term liabilities of Rs 14.35 Cr. Positive operating cash flow funded significant asset investments.